Congenital anomalies prevalence in Addis Ababa and the Amhara region, Ethiopia: a descriptive cross-sectional study.


Journal

BMC pediatrics
ISSN: 1471-2431
Titre abrégé: BMC Pediatr
Pays: England
ID NLM: 100967804

Informations de publication

Date de publication:
11 07 2019
Historique:
received: 10 12 2018
accepted: 24 06 2019
entrez: 13 7 2019
pubmed: 13 7 2019
medline: 1 9 2020
Statut: epublish

Résumé

During the first three months of pregnancy, the developing embryo may be susceptible to external and internal factors, which may lead to structural and functional congenital anomalies. The main objective of this study was to determine the prevalence of congenital anomalies in Addis Ababa and the Amhara region, Ethiopia. A descriptive cross-sectional study was conducted on children 0-17 years of age who visited the 16 selected hospitals in Addis Ababa and the Amhara Region between January 1 and July 5, 2015. The proportions of neonates, infants, and children with external and internal congenital anomalies whether the anomalies were major or minor were estimated. Out of 76,201 children, 1518 of whom 57.6% were male identified with congenital anomalies. The overall proportion of congenital anomaly was 1.99% (95% CI: 1.89-2.091) i.e., 199 per 10,000 children. The proportion of neural tube defects, orofacial clefts, masculo-skeletal system anomalies, syndrome disorders, and cardiovascular system problems were 40.3% 37.7-43, 23.3% 21.3-25.4, 23.1% 20.9-25.2, 8% 6.7-9.4, and 2.6% 1.8-3.4, with a 95% CI, respectively. The majority (72.5%) of the mothers were multigravidae; 38(2.5%) of the mothers and 32(2.1%) of the fathers had history of other children with congenital anomalies. Similarly, 20(1.3%) of the participant children's mothers and 17(1.1%) of the fathers had familial history of congenital anomaly. Iron folate and multivitamin use by mothers during preconception and early pregnancy was found to be low. Neural tube defects, orofacial clefts, and musculoskeletal anomalies were the observed prevalent problems. Maternal illness, viral infections, and malnutrition were seen in a significant number of the mothers. Iron folate/folic acid and multivitamin use by the mothers during and before pregnancy was very low.

Sections du résumé

BACKGROUND
During the first three months of pregnancy, the developing embryo may be susceptible to external and internal factors, which may lead to structural and functional congenital anomalies. The main objective of this study was to determine the prevalence of congenital anomalies in Addis Ababa and the Amhara region, Ethiopia.
METHODS
A descriptive cross-sectional study was conducted on children 0-17 years of age who visited the 16 selected hospitals in Addis Ababa and the Amhara Region between January 1 and July 5, 2015. The proportions of neonates, infants, and children with external and internal congenital anomalies whether the anomalies were major or minor were estimated.
RESULTS
Out of 76,201 children, 1518 of whom 57.6% were male identified with congenital anomalies. The overall proportion of congenital anomaly was 1.99% (95% CI: 1.89-2.091) i.e., 199 per 10,000 children. The proportion of neural tube defects, orofacial clefts, masculo-skeletal system anomalies, syndrome disorders, and cardiovascular system problems were 40.3% 37.7-43, 23.3% 21.3-25.4, 23.1% 20.9-25.2, 8% 6.7-9.4, and 2.6% 1.8-3.4, with a 95% CI, respectively. The majority (72.5%) of the mothers were multigravidae; 38(2.5%) of the mothers and 32(2.1%) of the fathers had history of other children with congenital anomalies. Similarly, 20(1.3%) of the participant children's mothers and 17(1.1%) of the fathers had familial history of congenital anomaly. Iron folate and multivitamin use by mothers during preconception and early pregnancy was found to be low.
CONCLUSION
Neural tube defects, orofacial clefts, and musculoskeletal anomalies were the observed prevalent problems. Maternal illness, viral infections, and malnutrition were seen in a significant number of the mothers. Iron folate/folic acid and multivitamin use by the mothers during and before pregnancy was very low.

Identifiants

pubmed: 31296186
doi: 10.1186/s12887-019-1596-2
pii: 10.1186/s12887-019-1596-2
pmc: PMC6625051
doi:

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

234

Références

Am J Clin Nutr. 2005 May;81(5):1213S-1217S
pubmed: 15883454
Birth Defects Res A Clin Mol Teratol. 2006 Jun;76(6):467-73
pubmed: 16933210
J Toxicol Environ Health A. 2007 Jan;70(1):7-18
pubmed: 17162495
N Engl J Med. 2007 Jul 12;357(2):135-42
pubmed: 17625125
Int J Urol. 2009 Jan;16(1):49-57
pubmed: 19120526
Turk J Pediatr. 2009 Sep-Oct;51(5):444-52
pubmed: 20112599
Eur J Hum Genet. 2011 Feb;19(2):231-4
pubmed: 20736977
Can J Public Health. 2010 May-Jun;101(3):230-4
pubmed: 20737815
Early Hum Dev. 2010 Nov;86(11):737-41
pubmed: 20832202
Pediatrics. 2010 Oct;126(4):e843-50
pubmed: 20876169
Birth Defects Res A Clin Mol Teratol. 2010 Dec;88(12):1008-16
pubmed: 20878909
Arch Argent Pediatr. 2010 Oct;108(5):409-17
pubmed: 21132229
J Pediatr Urol. 2012 Apr;8(2):121-6
pubmed: 21930431
World J Pediatr. 2011 Nov;7(4):302-10
pubmed: 22015723
World J Pediatr. 2011 Nov;7(4):331-6
pubmed: 22015725
Pan Afr Med J. 2011;8:14
pubmed: 22121423
Oman Med J. 2010 Jan;25(1):37-40
pubmed: 22125696
Public Health Rep. 2012 Jan-Feb;127(1):52-61
pubmed: 22298922
BMC Res Notes. 2012 Jul 10;5:177
pubmed: 22472067
Arch Gynecol Obstet. 2012 Oct;286(4):889-92
pubmed: 22660889
Eur J Hum Genet. 2013 Jan;21(1):27-33
pubmed: 22713804
Int J Environ Res Public Health. 2012 May;9(5):1732-47
pubmed: 22754469
Occup Environ Med. 2012 Aug;69(8):534-42
pubmed: 22782864
J Pediatr. 2013 Jan;162(1):108-13.e2
pubmed: 22835879
BMC Pediatr. 2012 Aug 18;12:125
pubmed: 22900612
PLoS One. 2012;7(10):e45530
pubmed: 23056206
Ital J Pediatr. 2012 Dec 07;38:68
pubmed: 23217204
BJOG. 2013 May;120(6):707-16
pubmed: 23384325
Przegl Lek. 2012;69(10):1011-4
pubmed: 23421081
PLoS One. 2013;8(3):e58690
pubmed: 23555592
J Assist Reprod Genet. 2013 Jun;30(6):799-805
pubmed: 23615726
Med Confl Surviv. 2013 Jan-Mar;29(1):26-44
pubmed: 23729096
Pediatr Dent. 2013 May-Jun;35(3):279-83
pubmed: 23756316
J Pediatr. 2013 Oct;163(4):1163-8
pubmed: 23885965
Birth Defects Res A Clin Mol Teratol. 2013 Aug;97(8):564-70
pubmed: 23913528
Am J Med Genet A. 2013 Oct;161A(10):2444-52
pubmed: 23950097
Int J Environ Res Public Health. 2013 Aug 07;10(8):3465-82
pubmed: 23965922
J Clin Neonatol. 2013 Jul;2(3):131-4
pubmed: 24251257
Environ Res. 2014 Jan;128:9-14
pubmed: 24407474
BMC Res Notes. 2014 Mar 29;7:195
pubmed: 24679067
Mater Sociomed. 2014 Jun;26(3):158-62
pubmed: 25126007
Pediatr Neonatol. 2015 Feb;56(1):25-30
pubmed: 25267275
Pan Afr Med J. 2015 Feb 18;20:153
pubmed: 26525082
J Popul Ther Clin Pharmacol. 2015;22(3):e198-210
pubmed: 26567551
Sudan J Paediatr. 2014;14(2):49-60
pubmed: 27493405
PLoS One. 2016 Oct 5;11(10):e0161998
pubmed: 27706169
BMC Med. 2017 Jan 31;15(1):20
pubmed: 28137281
Int J Environ Res Public Health. 2017 Mar 10;14(3):
pubmed: 28287452
BMC Pediatr. 2018 Apr 25;18(1):142
pubmed: 29699508
S Afr Med J. 1995 Jan;85(1):11-5
pubmed: 7784907

Auteurs

Molla Taye (M)

Department of Anatomy, School of Medicine, College of Medicine and Health Sciences, the University of Gondar, P.O. Box: 196, Central Gondar, Ethiopia. mollataye2@gmail.com.

Mekbeb Afework (M)

Department of Anatomy, School of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.

Wondwossen Fantaye (W)

School of Dentistry, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.

Ermias Diro (E)

Department of Internal Medicine, School of Medicine, College of Medicine and Health Sciences, the University of Gondar, Central Gondar, Ethiopia.

Alemayehu Worku (A)

School of Public Health, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH